Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: Effect of insulin and nerve growth factor

British Journal of Pharmacology

Volumn 124, Issue 7, 1998, Pages 1573-1579

  Bennett, Gavin S ^b   Garrett, Neil E ^a   Diemel, Lara T ^a   Brain, Susan D ^b   Tomlinson, David R ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CGRP; Diabetic neuropathy; Insulin; Nerve growth factor; Neurogenic inflammation substance P; NGF; Rat skin microvasculature

Indexed keywords

INSULIN; LINPLANT; NERVE GROWTH FACTOR; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; EXTRAVASATION; LASER DOPPLER FLOWMETRY; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SKIN BLOOD FLOW; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; MALE; NERVE GROWTH FACTORS; RATS; RATS, WISTAR; SKIN; STREPTOZOCIN; SUBSTANCE P; VASODILATION;

EID: 0031829117     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701986     Document Type: Article

References (28)

1. ANAND, P. (1986). Neurotrophins and peripheral neuropathy. Phil. Trans. R. Soc. Lond. B., 351, 449-454.
2. ANAND, P., WARNER, G., PARRETT, A., KOPELMAN, P., GHATEI, M.A., BLOOM, S.R., SINICROPI, D.V. & WILLIAMS CHESTNUT, R.E. (1994). Nerve growth factor related small fibre dysfunction in human diabetic polyneuropathy. Ann. Neurol., 36, 284a.
3. APFEL, S.C., AREZZO, J.C., BROWNLEE, M., FEDEROFF, H. & KESSLER, J.A. (1994). Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res., 634, 7-12.
4. ARONIN, N., LEEMAN, S.E. & CLEMENTS, R.S., JR. (1987). Diminished flare response in neuropathic patients: comparison of effects of substance P, histamine and capsaicin. Diabetes. 36, 1139-1143.
5. BRAIN, S.D. (1996). Sensory neuropeptides in the skin. In Neurogenic Inflammation, eds. P. Geppetti and P. Holzer, pp. 229-224. Boca Raton, Florida: CRC Press Inc.
6. BRAIN, S.D. & WILLIAMS, T.J. (1985). Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol., 86, 855-860.
7. DIEMEL, L.T., BREWSTER, W.J., FERNHOUGH, P. & TOMLINSON, D.R. (1994). Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol. Brain Res., 21, 171-175.
8. DIEMEL, L.T., STEVENS, E.J., WILLARS, G.B. & TOMLINSON, D.R. (1992). Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition. Neurosci. Lett., 137, 253-256.
9. DYCK, P.J. (1992). New understanding and treatment of diabetic neuropathy. N. Engl. J. Med., 326, 1287-1288.
10. 1 receptor antagonist. Eur. J. Pharmacol., 250, 403-413.
11. ESCOTT, K.J., BEATTIE, D.T., CONNOR, H.E. & BRAIN, S.D. (1995). Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide. Brain Res., 669, 93-99.
12. ESCOTT, K.J. & BRAIN, S.D. (1993). Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br. J. Pharmacol., 110, 772-776.
13. FERNYHOUGH, P., DIEMEL, L.T., BREWSTER, W.J. & TOMLINSON, D.R. (1995). Altered neurotrophin mRNA in peripheral nerve and skeletal muscle of experimentally diabetic rats. J. Neurochem., 64, 1231-1237.
14. GAMSE, R. & JANCSÓ, G. (1985). Reduced neurogenic changes in inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion. Eur. J. Pharmacol., 118, 175-180.
15. GAMSE, R. & SARIA, A. (1987). Antidromic vasodilatation in the rat hindpaw measured by laser Doppler flowmetry: pharmacological modulation. J. Auton. Nerv. Syst., 19, 105-111.
16. GARCIA LEME, J., BÖHM, G.M., MIGLIORINI, R.H. & DE SOUZA, M.Z.A. (1974). Possible participation of insulin in the control of vascular permeability. Eur. J. Pharmacol., 29, 298-306.
17. GARRETT, N.E., KIDD, B.L., CRUWYS, S.C. & TOMLINSON, D.R. (1996). Effect of streptozotocin-diabetes on knee joint inflammation-induced changes in substance P and nerve growth factor in the rat. Mol. Brain Res., 42, 272-278.
18. GARRETT, N.E., MALCANGIO, M., DEWHURST, M. & TOMLINSON, D.R. (1997). Alpha-lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci. Lett., 222, 191-194.
19. GYÖRFI, A., FAZEKAS, A., FEHÉR, E., ENDER, F. & ROSIVALL, L. (1996). Effects of streptozotocin-induced diabetes on neurogenic inflammation of gingivomucosal tissue in the rat. J. Periodont. Res., 31, 249-255.
20. HELLWEG, R., RAIVICH, G., HÄRTUNG, H.-D., HOCK, C. & KREUTZBERG, G.W. (1984). Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol., 130, 24-30.
21. HOLZER, P. (1992). Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rer. Physiol. Biochem. Pharmacol., 121, 49-146.
22. LEVY, D.M., TERENGHI, G., GU, X.-H., ABRAHAM, R.R., SPRINGALL, D.R. & POLAK, J.M. (1992). Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia, 35, 889-897.
23. LINDSAY, R.M. & HARMAR, A.J. (1989). Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature, 337, 362-364.
24. LINDSAY, R.M., WIEGAND, S.J., ALTAR, C.A. & DISTEFANO, P.S. (1994). Neurotrophic factors: From molecule to man. Trends in Neurosciences, 17, 182-190.
25. ngfr. Mol. Brain Res., 37, 166-174.
26. SINEY, L. & BRAIN, S.D. (1996). Involvement of sensory neuropeptides in the development of plasma extravasation in rat dorsal skin following thermal injury. Br. J. Pharmacol., 117, 1065-1070.
27. STEPHENS, M.J., FELDMAN, E.L. & GREENE, D.A. (1995). The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diab. Med., 12, 566-579.
28. STEVENS, E.J., CARRINGTON, A.L. & TOMLINSON, D.R. (1994). Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia, 37, 43-48.